Literature DB >> 11316262

Swelling-activated taurine and K+ transport in human cervical cancer cells: association with cell cycle progression.

M R Shen1, C Y Chou, J C Ellory.   

Abstract

The aim of this study was to investigate swelling-activated taurine and K+ transport in human cervical cancer cells under various culture conditions, testing the hypothesis that the progression of cell cycle was accompanied by differential activities of swelling-activated transport pathways. Aphidicolin, an inhibitor of deoxyribonucleic acid (DNA) synthesis, was used to synchronize the cell cycle. The distribution of cell cycle stage was determined by fluorescence-activated cell sorting (FACS). Hypotonicity activated taurine efflux, which was sensitive to tamoxifen and 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB). Cell swelling also induced both Cl- -dependent and -independent K+ (86Rb+) efflux, presumably mediated by KCl cotransport (KCC) and Ca2+ -activated K+ channels, respectively. Cell cycle arrest in G0/G1 was accompanied by a remarkable decrease in the rate constant for swelling-activated taurine efflux, from 0.20+/-0.007 to 0.026+/-0.002 min(-1) (n=6). The activity of swelling-activated taurine efflux recovered progressively on re-entry into the cell cycle. After removal of aphidicolin and culture with 10% fetal calf serum for 10 h, the rate constant increased significantly from 0.026+/-0.002 to 0.093+/-0.002 min(-1) (n=6). After 24 h release from aphidicolin, the efflux rate constant had increased further to 0.195+/-0.006 min(-1) (n=6), a value not significantly different from that in normally proliferating cells. The differential activities of swelling-activated taurine transport matched well with our previous study showing a volume-sensitive anion channel associated with cell cycle progression. In contrast to the differential activities of swelling-activated taurine transport, swelling-activated K+ (86Rb+) transport was independent of the progression of cell cycle. Most importantly, pharmacological blockade of swelling-activated taurine efflux by tamoxifen or NPPB caused proliferating cervical cancer cells to arrest in G0/G1, suggesting that the activity of this efflux was associated with G1/S checkpoint progression. This study provides new and important information on the functional significance of swelling-activated transport system in the regulation of cell cycle clock of human cervical cancer cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316262     DOI: 10.1007/s004240000476

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  6 in total

1.  Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.

Authors:  Rong Tao; Chu-Pak Lau; Hung-Fat Tse; Gui-Rong Li
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-24       Impact factor: 4.249

2.  Inhibition of ERK and JNK decreases both osmosensitive taurine release and cell proliferation in glioma cells.

Authors:  Mark J Belsey; Andrew R L Davies; Harry J Witchel; Roland Z Kozlowski
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

3.  Human cervical cancer cells use Ca2+ signalling, protein tyrosine phosphorylation and MAP kinase in regulatory volume decrease.

Authors:  M R Shen; C Y Chou; J A Browning; R J Wilkins; J C Ellory
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

4.  Trafficking and recycling of the connexin43 gap junction protein during mitosis.

Authors:  Daniela Boassa; Joell L Solan; Adrian Papas; Perry Thornton; Paul D Lampe; Gina E Sosinsky
Journal:  Traffic       Date:  2010-09-10       Impact factor: 6.215

5.  A case study of primary malignancy of buccal mucosa using proton HR-MAS NMR spectroscopy on tissue specimens.

Authors:  Rohit Khanna; Kapila Kumar; Raja Roy
Journal:  J Oral Biol Craniofac Res       Date:  2017-10-05

6.  Hypotonic cell swelling stimulates permeability to cAMP in a rat colonic cell line.

Authors:  P E Golstein; A Daifi; R Crutzen; A Boom; W Van Driessche; R Beauwens
Journal:  Pflugers Arch       Date:  2004-01-16       Impact factor: 3.657

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.